Polymorphism of Glutathione S-Transferase(GST)M1, GSTT1, GSTP1 and Genetic Susceptibility to Head and Neck Squamous Cell Carcinoma in Korean Population

한국인 두경부 편평세포암 환자에서 Glutathione S-transferase(GST)M1, GSTT1 및 GSTP1유전자 다형성 및 유전적 감수성

  • Tae Kyung (Department of Otolaryngology, College of Medicine, Hanyang University) ;
  • Seo In-Seok (Department of Otolaryngology, College of Medicine, Hanyang University) ;
  • Kang Mee-Jeong (Department of Otolaryngology, College of Medicine, Hanyang University) ;
  • Cho Seok-Hyun (Department of Otolaryngology, College of Medicine, Hanyang University) ;
  • Kim Kyung-Rae (Department of Otolaryngology, College of Medicine, Hanyang University) ;
  • Lee Hyung-Seok (Department of Otolaryngology, College of Medicine, Hanyang University)
  • 태경 (한양대학교 의과대학 이비인후과학교실) ;
  • 서인석 (한양대학교 의과대학 이비인후과학교실) ;
  • 강미정 (한양대학교 의과대학 이비인후과학교실) ;
  • 조석현 (한양대학교 의과대학 이비인후과학교실) ;
  • 김경래 (한양대학교 의과대학 이비인후과학교실) ;
  • 이형석 (한양대학교 의과대학 이비인후과학교실)
  • Published : 2002.11.01

Abstract

Objectives: Most of human cancers may result from exposure to environmental carcinogens, and individual effectiveness in the detoxification of these chemicals will influence susceptibility to malignant disease. Glutathione S-Transferases(GSTs) enzymes are involved in the detoxification of active metabolites of many carcinogens from tobacco smoke and may be important in modulating susceptibility to smoke-related cancer. The purpose of this study is to determine the polymorphism of GSTM1, GSTT1, and GSTP1 in control group and head and neck squamous cell carcinoma group of Korean, and to investigate the effect of GSTs polymorphism on the risk of head and neck cancer. Materials and Methods: A hospital-based case-control study was performed with a group of 133 control individual and 136 head and neck squamous cell carcinoma patients. The polymorphisms of GSTs were analysed using polymerase chain reaction in GSTM1 and GSTTl, and polymerase chain reaction-restriction fragment length polymorphism in GSTP1. Results: The relative risk (odds ratio) of GSTM(-) genotype was 1.14(95% CI, 0.70-1.85) compared to GSTM1(+). The odds ratio of GSTTl(-) genotype was 0.91(95% CI, 0.55-1.50). In old age($65$) group, the odds ratio of GSTT1(-) genotype was 5.2(95% CI, 1.53-17.89). The GSTP1 Val/Val genotype conferred a 1.7-fold risk(95% CI, 0.40-7.34) of head and neck cancer compared with GSTP1 Ile/Ile genotype. Among the combined genotypes of GSTs, GSTM1(-)/GSTT1(+)/GSTP1 Val/Val and GSTM1(-)/GSTTl(-)/GSTP1 Ile/Val genotypes conferred a 2.6-fold and 1.3-fold risk(95% CI, 0.24-14.15 and 0.43-3.14) compared with the GSTM1(+)/GSTTl(+)/GSTP1 Ile/Ile genotype, respectively. Conclusion: Polymorphism of GSTs might modulate susceptibility to head and neck cancer in Korean population. The genotype of GSTP1 Val/Val and combined genotypes of GSTM1(-)/GSTT1(+)/GSTP1 Val/Val, and GSTM1(-)/GSTT1(-)/GSTP1 Ile/Val might be important risk factors to determine the individual susceptibility to head and neck squamous cell carcinoma.

Keywords

References

  1. Lieshout EM, Roelofs HM, Peters WH, Manni JJ : Glutathione S-transferase M1 and T1 and cytochrome P4501A1 polymorphism in relation to the risk for benign and malignant head and neck lesions. Cancer. 1998 ; 81 : 936-943
  2. Shin CS, Ahn KS, Tae K, Lee HS, Kim HJ, Kong G : Genetic susceptibility of CYP1A1 and GSTM1 to the risk for Korean head and neck squamous cell carcinoma patients. Korean J Otolaryngol. 1999; 42 : 202-208
  3. Ko KM, Ahn KS, Tea K, Lee SH, Kong G : Genetic polymorphism of cytochrome P4501Al exon 7 and glutathione S-transferase M1 in the head and neck squamous cell carcinoma patients. Korean J Otolaryngol. 1999 ; 42 : 1405-1412
  4. Matthis C, Bockmuhl D, Jahnke V, et al : Polymorphism in cytochrome P450, CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers : studies in upper aerodigestive tract cancers. Pharmacogenetics. 1998 ; 8 : 91-100
  5. Nakachi K, Imai K, Hayashi S, Watanabe J, Kawajiri K : Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Res. 1991 ; 51 : 5177-5180
  6. Jourenkova N, Reinikainen M, Bouchardy C, Dayer P, Benhamou S, Hirvonen A : Larynx cancer risk in relation to glutathione S-transferase M1 and T1 genotypes and tobacco smoking. Cancer Epidemiology Biomarkers & Prevention. 1998 ; 7 : 19-24
  7. Board PJ : Biochemical genetics of glutathione S-transferase in man. Am J Hum Genet. 1981 ; 33 : 36-43
  8. Board P, Coggan M, Johnston P, Ross V, Suzuki T : Genetic heterogeneity of the human glutathione transferase : a complex of gene families. Pharmacol. 1990 ; 48 : 357-369
  9. Mark WA, Monesola A, Margaret FB, Ann KD : Polymorphisms in GSTP1, GSTM1 and GSTT1 and susceptibility to colorectal cancer. Cancer Epidemiology Biomarkers & Prevention. 1999 ; 8 : 289-292
  10. Rebbeck TR : Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiology Biomarkers & Prevention. 1997 ; 6 : 733-743
  11. Park JY, Stimson PS, Jordan CS, Tajinder K, Philip L : Association between glutathione S-transferase $\pi$ genetic polymorphisms and oral cancer risk. Pharmarcogenetics. 1999 ; 9 : 497-504
  12. Matthias C, Bockmuhl U, Jahnke V, et al : The glutathione S-transferase GSTP1 polymorphism : effects on susceptubility to oral/pharyngeal and laryngeal carcinomas. Pharmacogenetics. 1998 ; 8: 1-6 https://doi.org/10.1097/00008571-199802000-00001
  13. Comstock KE, Sanderson BJS, Claflin G, Henner WD : GSTM1-gene deletion determined by polymerase chain reaction. Nucleic Acids Res. 1990 ; 18 : 3670
  14. Warwick A, Sarhanis P, Redman G, Taylor JB, Ketterer B : Theta class glutathione S-transferase GSTT1 genotypes and susceptibility to cervical neoplasia : Interactions with GSTM1, CYP2D6 and smoking. Carcinogenesis. 1994 ; 15 : 2841-2845 https://doi.org/10.1093/carcin/15.12.2841
  15. Watson MA, Stewart RK, Smith BJ, Massey TE : Human glutathione S-transferase P1 polymorphism : relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis. 1998 ; 19 : 275-280 https://doi.org/10.1093/carcin/19.2.275
  16. Oude MB, Kieshout EM, Roelofs HM, Peters WH, Manni JJ : Glutathione S-transferase M1 and T1 and cytochrome P4501A1 polymorphism in relation to the risk for benign and malignant head and neck lesions. Cancer. 1998 ; 82 (5) : 936-943 https://doi.org/10.1002/(SICI)1097-0142(19980301)82:5<936::AID-CNCR20>3.0.CO;2-0
  17. Seidegard J, Ekstrom G : The role of human glutathione transferases and epoxide hydrolases in the metabolism of xenobiotics. Environ Health Perspect. 1997 ; 105 : 791-799 https://doi.org/10.2307/3433285
  18. Trizna Z, Clayman GL, Spitz MR, Briggs KL, Goepfert H : Glutathione S-transferase genotypes as risk factors for head and neck cancer. Am J surgery. 1995 ; 170 : 499-501 https://doi.org/10.1016/S0002-9610(99)80339-0
  19. Jahnke V, Matthias C, Fryer A, Strange R : Glutathione S-transferase and Cytochrome-P-450 polymorphism as risk factor for squamous cell carcinoma ofthe larynx. Am J Surg. 1996 ; 172 : 671-673 https://doi.org/10.1016/S0002-9610(96)00298-X
  20. Kihara M, Kubota A, Furukawa M, Kimura H : GSTM1 gene polymorphism as a possible marker for susceptibility to head and neck cancers among Japanese smokers. Cancer Letters. 1997 ; 112 : 257-262 https://doi.org/10.1016/S0304-3835(96)04584-3